Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of MXN 4.36 trillion. The enterprise value is 4.85 trillion.

Market Cap	4.36T
Enterprise Value	4.85T

Important Dates

The next estimated earnings date is Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	Mar 17, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.24%
Shares Change (QoQ)	-0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.52B

Valuation Ratios

The trailing PE ratio is 12.22.

PE Ratio	12.22
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	25.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.24, with an EV/FCF ratio of 12.86.

EV / Earnings	13.60
EV / Sales	3.78
EV / EBITDA	8.24
EV / EBIT	9.76
EV / FCF	12.86

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.83.

Current Ratio	1.36
Quick Ratio	0.87
Debt / Equity	0.83
Debt / EBITDA	1.30
Debt / FCF	2.11
Interest Coverage	19.58

Financial Efficiency

Return on equity (ROE) is 40.79% and return on invested capital (ROIC) is 19.62%.

Return on Equity (ROE)	40.79%
Return on Assets (ROA)	13.90%
Return on Invested Capital (ROIC)	19.62%
Return on Capital Employed (ROCE)	28.06%
Revenue Per Employee	18.07M
Profits Per Employee	4.82M
Employee Count	75,000
Asset Turnover	0.57
Inventory Turnover	2.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.01% in the last 52 weeks. The beta is 0.36, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.36
52-Week Price Change	-18.01%
50-Day Moving Average	1,854.96
200-Day Moving Average	2,085.90
Relative Strength Index (RSI)	34.30
Average Volume (20 Days)	6,930

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.31

Income Statement

In the last 12 months, Merck & Co. had revenue of MXN 1.34 trillion and earned 356.67 billion in profits. Earnings per share was 140.44.

Revenue	1.34T
Gross Profit	1.03T
Operating Income	518.62B
Pretax Income	415.41B
Net Income	356.67B
EBITDA	607.08B
EBIT	518.62B
Earnings Per Share (EPS)	140.44

Full Income Statement

Balance Sheet

The company has 285.24 billion in cash and 797.45 billion in debt, giving a net cash position of -512.20 billion.

Cash & Cash Equivalents	285.24B
Total Debt	797.45B
Net Cash	-512.20B
Net Cash Per Share	n/a
Equity (Book Value)	966.27B
Book Value Per Share	381.80
Working Capital	215.92B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 447.34 billion and capital expenditures -70.26 billion, giving a free cash flow of 377.07 billion.

Operating Cash Flow	447.34B
Capital Expenditures	-70.26B
Free Cash Flow	377.07B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.09%, with operating and profit margins of 38.79% and 26.68%.

Gross Margin	77.09%
Operating Margin	38.79%
Pretax Margin	31.07%
Profit Margin	26.68%
EBITDA Margin	45.40%
EBIT Margin	38.79%
FCF Margin	28.20%

Dividends & Yields

This stock pays an annual dividend of 61.45, which amounts to a dividend yield of 3.47%.

Dividend Per Share	61.45
Dividend Yield	3.47%
Dividend Growth (YoY)	19.61%
Years of Dividend Growth	1
Payout Ratio	45.80%
Buyback Yield	0.24%
Shareholder Yield	3.71%
Earnings Yield	8.18%
FCF Yield	8.65%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.65.

Altman Z-Score	4.65
Piotroski F-Score	n/a